Pliant Therapeutics, Inc.

PLRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$71,188$63,234$33,685$51,665
Short-Term Investments$284,536$431,011$297,502$148,931
Receivables$2,302$2,997$3,144$2,466
Inventory$0$0$0$0
Other Curr. Assets$4,238$8,260$5,980$6,379
Total Curr. Assets$362,264$505,502$340,311$209,441
Property Plant & Equip (Net)$32,768$4,778$9,908$10,936
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,917$1,874$394$838
Total NC Assets$34,685$6,652$10,302$11,774
Other Assets$0$0$0$0
Total Assets$396,949$512,154$350,613$221,215
Liabilities
Payables$5,960$4,531$1,580$2,971
Short-Term Debt$542$1,318$2,457$1,869
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$26,716$22,675$19,876$11,991
Total Curr. Liab.$33,218$28,524$23,913$16,831
LT Debt$59,650$10,054$13,358$5,325
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$59,650$10,054$13,358$5,325
Other Liabilities$0$0$0$0
Cap. Leases$29,981$1,318$5,886$7,194
Total Liabilities$92,868$38,578$37,271$22,156
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$5$3
Retained Earnings-$710,052-$499,748-$338,412-$215,091
AOCI$321$345-$1,958-$201
Other Equity$1,013,806$972,973$653,707$414,348
Total Equity$304,081$473,576$313,342$199,059
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$396,949$512,154$350,613$221,215
Net Debt-$10,996-$51,862-$17,870-$44,471